{"member_organisations": "", "identification_number": "940251520152-08", "fields_of_interest": "General and Institutional Affairs, Economy, finance and the euro, Trade, Competition, Consumers, Culture, Customs, Employment and Social Affairs, Business and Industry, Environment, Taxation, Justice and Fundamental Rights, Single market, Research and innovation, External Relations, Public Health, Digital economy and society, Borders and Security", "head_office_address": "Thurgauerstrasse 40", "full_time_equivalent_fte": "0,75", "person_with_legal_responsibility": "Jacek Glinka", "industry_forums": "", "grants": "", "country_code": "ch", "inter_groups": "", "eu_initiatives": "ATMP Regulation \nClinical Trials Regulation \nData Protection Regulation \nMedical Devices Regulation \nIn-Vitro Diagnostic Regulation \nPaediatric Regulation \nAccess to Innovation \nBiosimilars \nIndustrial Policy \nEU Trade Policy \nHealth Systems Performance Assessment \nHealth Technology Assessment \nPharmaceuticals in the environment", "level_of_interest": "global", "organisation_name": "Mylan GmbH (Mylan)", "belgium_office_post_code": "1560", "number_of_persons_involved": "2", "person_in_charge_of_eu_relations": "Victor Mendonca", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "8.5522686", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "(+32)10476224", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "Terhulpsesteenweg 6A", "persons_accredited_for_access_to_european_parliament_premises": "DELANEY#David, RODRIGUES FRANCO MENDES#Paulo Jorge", "registration_date": "04/01/2016", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.mylan.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Zurich", "membership": "Medicines for Europe (MfE)", "head_office_post_code": "8050", "position": "Head of Policy & Market Access - Europe", "financial_year_start_date": "01/01/2016", "head_office_country": "Switzerland", "number_of_ep_accredited_persons": "2", "relevant_communication": "", "financial_year_end_date": "01/12/2016", "lat": "47.4148583", "estimate_of_costs_as_a_range": "100000-199999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "GmbH", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what\u2019s right, not what\u2019s easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world\u2019s largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time.", "belgium_office_city": "Hoeilaart", "head_office_phone": "(+41)443087575"}